Surgery Partners
SGRY
187 hedge funds and large institutions have $2.65B invested in Surgery Partners in 2026 Q2 according to their latest regulatory filings, with 35 funds opening new positions, 73 increasing their positions, 51 reducing their positions, and 27 closing their positions.
1,320% more call options, than puts
Call options by funds: $10.9M | Put options by funds: $768K
43% more repeat investments, than reductions
Existing positions increased: 73 | Existing positions reduced: 51
40% more capital invested
Capital invested by funds: $1.9B → $2.65B (+$753M)
30% more first-time investments, than exits
New positions opened: 35 | Existing positions closed: 27
25% more funds holding in top 10
Funds holding in top 10: 4 → 5 (+1)
3% more funds holding
Funds holding: 182 → 187 (+5)
2.31% less ownership
Funds ownership: 122.97% → 120.66% (-2.3%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
T. Rowe Price Investment Management
Baltimore,
Maryland
|
+$55.7M |
| 2 |
HPCM
Hein Park Capital Management
New York
|
+$15M |
| 3 |
HSBC Holdings
London,
United Kingdom
|
+$14.6M |
| 4 |
OCM
Oaktree Capital Management
Los Angeles,
California
|
+$12.1M |
| 5 |
Nomura Holdings
Tokyo,
Japan
|
+$11.3M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
KSCM
King Street Capital Management
New York
|
-$58.6M |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$22.7M |
| 3 |
GCM
Glenview Capital Management
New York
|
-$21.5M |
| 4 |
PCM
Pentwater Capital Management
Naples,
Florida
|
-$14.4M |
| 5 |
ICM
Irenic Capital Management
New York
|
-$8.48M |
SGRY Hedge Fund Activity: Q2 2026 in Review
187 of the 8,305 institutional investors tracked by Wall St. Rank reported a position in Surgery Partners (SGRY) for Q2 2026, worth a combined $2.65B — up 40% from $1.9B a quarter earlier.
Buyers outnumbered sellers: 35 funds opened new SGRY positions and 27 closed out — a net gain of 8 holders — while 73 added to existing stakes and 51 trimmed.
The largest buyer was T. Rowe Price Investment Management, adding an estimated $55.7M. The largest seller was King Street Capital Management, cutting an estimated $58.6M.
- 187 institutional investors held Surgery Partners (SGRY) as of Q2 2026, up from 182 in Q1 2026.
- Funds reported $2.65B of Surgery Partners stock for Q2 2026, up 40% quarter-over-quarter.
- 35 funds opened new Surgery Partners positions in Q2 2026 and 27 closed out, a net change of +8 holders.
- The largest Surgery Partners buyer in Q2 2026 was T. Rowe Price Investment Management, an estimated $55.7M added.
- The largest Surgery Partners seller in Q2 2026 was King Street Capital Management, an estimated $58.6M sold.
Based on aggregated 13F filings for Q2 2026.